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Phosphorylation of the MEKK Ste11p by the PAK-like kinase
Ste20p is required for MAP kinase signaling in vivo
Frank van Drogen*, Sean M. O’Rourke†, Volker M. Stucke*, Malika Jaquenoud*,
Aaron M. Neiman‡ and Matthias Peter*
Background: Many signals are transduced from the cell surface to the nucleus
through mitogen-activated protein (MAP) kinase cascades. Activation of MAP
kinase requires phosphorylation by MEK, which in turn is controlled by Raf, Mos
or a group of structurally related kinases termed MEKKs. It is not understood
how MEKKs are regulated by extracellular signals. In yeast, the MEKK Ste11p
functions in multiple MAP kinase cascades activated in response to
pheromones, high osmolarity and nutrient starvation. Genetic evidence suggests
that the p21-activated protein kinase (PAK) Ste20p functions upstream of
Ste11p, and Ste20p has been shown to phosphorylate Ste11p in vitro. 
Results: Ste20p phosphorylated Ste11p on Ser302 and/or Ser306 and Thr307
in yeast, residues that are conserved in MEKKs of other organisms. Mutating
these sites to non-phosphorylatable residues abolished Ste11p function,
whereas changing them to aspartic acid to mimic the phosphorylated form
constitutively activated Ste11p in vivo in a Ste20p-independent manner. The
amino-terminal regulatory domain of Ste11p interacted with its catalytic domain,
and overexpression of a small amino-terminal fragment of Ste11p was able to
inhibit signaling in response to pheromones. Mutational analysis suggested that
this interaction was regulated by phosphorylation and dependent on Thr596,
which is located in the substrate cleft of the catalytic domain. 
Conclusions: Our results suggest that, in response to multiple extracellular
signals, phosphorylation of Ste11p by Ste20p removes an amino-terminal
inhibitory domain, leading to activation of the Ste11 protein kinase. This
mechanism may serve as a paradigm for the activation of mammalian MEKKs. 
Background
Extracellular and intracellular stimuli control cell prolifera-
tion and morphological changes, and are important ele-
ments governing development of multicellular organisms.
Many signals are transduced by mitogen-activated protein
(MAP) kinase modules, which consist of a kinase cascade of
at least three kinases acting sequentially [1]; MAP kinases
are activated by phosphorylation by the MAP kinase kinase
MEK, which in turn is phosphorylated and activated by
Raf, Mos or a group of structurally related kinases termed
MEKK. Several MAP kinase modules have been identified
including the extracellular signal-regulated kinase (ERK)-
type modules, the Jun N-terminal kinase (JNK) or stress-
activated protein kinase (SAPK) modules and the kinases of
the p38 family. Some MAP kinase modules are bound to
scaffold molecules such as JIP1, which are thought to be
required for MAP kinase activation and may contribute to
specificity of signal transduction [2,3]. 
Saccharomyces cerevisiae uses five MAP kinase modules
which mediate cellular responses during mating and
sporulation, and allow cells to adapt rapidly to changes in
the environment such as high osmolarity, cell integrity,
starvation and filamentous growth [4]. In the mating
pathway, binding of pheromones to a seven-transmembrane
receptor leads to dissociation of the heterotrimeric G
protein, allowing Gβγ to interact with the downstream effec-
tors Ste5p [5–8] and Ste20p [9]. Ste5p is required to trans-
duce the signal and it interacts with the MEKK Ste11p, the
MEK Ste7p and the MAP kinase Fus3p, suggesting that it
functions as an adaptor for the mating pathway [10]. In the
nucleus, Fus3p phosphorylates the repressors Dig1p and
Dig2p [11,12], leading to their dissociation from the tran-
scriptional activator Ste12p. Ste11p is also required for
signal transduction in response to high extracellular osmo-
larity and filamentous growth conditions [4]. In the high
osmolarity pathway, Ste11p is part of a MAP kinase
module composed of Pbs2p and Hog1p, while nutrient
starvation triggers the formation of pseudohyphae by acti-
vating the MAP kinase Kss1p. 
Despite the detailed knowledge of MAP kinase modules,
their upstream activating mechanisms are poorly under-
stood. Genetic epistasis analysis in yeast and studies in
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mammalian systems indicate that Ste20p and other kinases
similar to the p21-activated kinase (PAK-like kinases)
function upstream of MEKKs such as Ste11p [13].
PAK-like kinases are activated by the small GTPases
Cdc42p or Rac1p [14] and are known to control gene
expression in the nucleus and cytoskeletal events. In mam-
malian cells, activation of Cdc42p stimulates the JNK/p38
subgroup of MAP kinases and also, in some cell types, the
ERK pathway [15,16]. Pak3 has been shown to phosphory-
late Raf-1 [17], suggesting that PAK-like kinases are
required for maximal activation of Raf by Ras. Similarly, in
yeast, purified Ste20p is able to phosphorylate Ste11p
in vitro [18], indicating that phosphorylation of Ste11p may
be involved in its activation in vivo. The kinase activity of
purified Ste11p is not altered by pheromone treatment,
suggesting that pheromones may not increase its catalytic
activity per se but may regulate the subcellular localization
of Ste11p or its interaction with an inhibitory protein [19].
Finally, Ste50p is able to bind the amino-terminal domain
of Ste11p [20,21]; ste50∆ cells exhibit multiple signaling
defects [22–24], suggesting that Ste50p functions as an
activator of Ste11p in vivo. 
Here, we have investigated the functional significance of
Ste11p phosphorylation by Ste20p. We found that Ste20p
phosphorylated three conserved sites in the amino terminus
of Ste11p, and mutational analysis indicated that phospho-
rylation of these sites was required to activate Ste11p in vivo
in response to pheromones, high osmolarity and pseudohy-
phal growth conditions. Our results strongly suggest that
phosphorylation relieves inhibition of the catalytic domain,
which is exerted intramolecularly by its own amino-termi-
nal regulatory domain. Taken together, our results provide
a molecular mechanism for the activation of Ste11p by
Ste20p in response to extracellular signals, which may serve
as a paradigm for the activation of mammalian MEKKs. 
Results
Ste11p is phosphorylated in vivo in a STE20-dependent
manner
To examine whether Ste11p is phosphorylated in vivo,
wild-type cells expressing a kinase-inactivated form of
Ste11p (Ste11p-K444R) fused to gluthathione-S-trans-
ferase (GST) were labeled with 32P-orthophosphate and
either treated or not treated with α-factor. Ste11p was then
purified using GST affinity beads (Figure 1a). In response
to α-factor, GST–Ste11-K444R was readily phosphorylated
(lanes 3,4), predominantly on serine residues (Figure 1c,
left panel). In vivo, phosphorylation of GST–Ste11-K444R
was dependent on Ste20p (lane 5); in vitro, purified Ste20p
(Figure 1b, lane 6), but not a kinase-inactivated form of
Ste20p (Ste20p-K649R; lane 7), was able to phosphorylate
GST–Ste11-K444R, suggesting that Ste20p may directly
phosphorylate Ste11p. Deletion analysis indicated that
residues primarily in the amino-terminal regulatory domain
of Ste11p were phosphorylated (data not shown), and
within this region, Ste11p-like kinases from several species
contain a conserved motif with serine and threonine
residues (Figure 1d). To test whether these residues were
phosphorylated by Ste20p, we mutated them to non-phos-
phorylatable alanine residues (Ste11p-Ala3) and expressed
wild-type or mutant Ste11 proteins as GST fusions in
Escherichia coli. Purified Ste20p was unable to phosphory-
late GST–Ste11p175–424-Ala3 (Figure 1e, lane 3), whereas
wild-type GST-Ste11p175–424 was phosphorylated (lane 2),
indicating that Ser302 and/or Ser306 and Thr307 are phos-
phorylated by Ste20p in vitro. Importantly, phosphoryla-
tion of full-length GST–Ste11p-Ala3 was strongly reduced
in 32P-orthophosphate-labeled cells treated with α-factor
(Figure 1e), suggesting that these sites are indeed phos-
phorylated in vivo in response to pheromones. 
Phosphorylation of Ste11p is functionally relevant in vivo
To examine whether phosphorylation of these sites is bio-
logically relevant in vivo, we transformed ste11∆ cells
(YMP518) with either a control plasmid (vector) or plas-
mids expressing, from the endogenous promoter, wild-
type Ste11p, Ste11p-Ala3 or Ste11p in which Ser302,
Ser306 and Thr307 were mutated to aspartic acid (Ste11p-
Asp3; see below) and determined the ability of these cells
to respond to pheromones, assayed by arrest of the cell
cycle, induction of the transcriptional reporter FUS1–lacZ,
and mating (Figure 2a–c). Although the Ste11p-Ala3
protein was expressed at wild-type levels (Figure 3a; data
not shown), the mutated protein was unable to function in
the pheromone response pathway, indicating that phos-
phorylation of these residues is important for activation of
Ste11p in vivo. In contrast, plasmids containing STE11
harboring single mutations in any of these sites functioned
efficiently in all assays (data not shown), suggesting that
more than one of the residues needs to be phosphorylated
to fully activate Ste11p in vivo. Wild-type cells over-
expressing Ste11p-Ala3 exhibited poor induction of the
FUS1–lacZ reporter (Figure 3c) and failed to arrest the cell
cycle in response to pheromones (Figure 3b), suggesting
that overexpression of Ste11p-Ala3 acts in a dominant-
negative fashion to interfere with Ste11p function. We
conclude that phosphorylation of Ser302 and/or Ser306
and Thr307 is required for Ste11p function in vivo. To
determine whether phosphorylation was sufficient to acti-
vate Ste11p in vivo, we mutated these residues to aspartic
acid residues in an attempt to mimic the phosphorylated
form of Ste11p (Ste11p-Asp3). Interestingly, overexpres-
sion of Ste11p-Asp3 but not kinase-inactive Ste11p-Asp3-
K444R resulted in activation of the mating pathway in the
absence of pheromones (Figure 2d,e). Importantly, activa-
tion of the mating pathway by Ste11p-Asp3 required
Ste7p but was independent of Ste20p (Figure 2f), consis-
tent with the idea that Ste20p phosphorylates and thereby
activates Ste11p. Taken together, these results suggest
that phosphorylation of Ser302 and/or Ser306 and Thr307
is necessary and sufficient for activation of Ste11p in vivo. 
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Ste11p not only functions in the mating pathway but is also
required to signal in response to high osmolarity and
during pseudohyphal growth [4]. Nutrient starvation trig-
gers the formation of pseudohyphae by activating the MAP
kinase Kss1p in a STE20-dependent manner [25]. Interest-
ingly, ste11∆ cells expressing Ste11p-Ala3 from the endo-
genous promoter were unable to form pseudohyphae
(Figure 4a; middle panel), whereas wild-type Ste11p (left
panel) or Ste11p-Asp3 (right panel) complemented the
defect, suggesting that phosphorylation of Ste11p by
Ste20p is required for pseudohyphal growth. In the high
osmolarity response pathway, Ste11p is part of a MAP
kinase module composed of Pbs2p and Hog1p. In addition,
high osmolarity conditions also activate Hog1p indepen-
dently of Ste11p by a pathway that requires Ssk1p [26,27].
Addition of NaCl induced phosphorylation of the MAP
kinase Hog1p on Tyr176 in ste11∆ ssk1∆ cells (SO419)
expressing wild-type Ste11p, but not in ste11∆ ssk1∆ cells
expressing Ste11p-Ala3 (Figure 4b, lower panel), suggest-
ing that phosphorylation of Ste11p is required to activate
Hog1p in response to high osmolarity. As expected,
expression of Ste11p-Ala3 failed to restore growth of
ste11∆ ssk1∆ cells on high osmolarity medium (Figure 4c).
When Ste11p-Asp3 was overexpressed, tyrosine phospho-
rylation (Figure 4b, upper panel) and nuclear localization
of Hog1p (data not shown) was detected even in the
absence of high salt, demonstrating that Ste11p-Asp3 was
able to constitutively activate both the high osmolarity and
pheromone response pathways. Consistent with these
results, cells overexpressing Ste11p-Asp3 exhibited a
growth defect, which was rescued only by simultaneous
deletion of Ste7p and Pbs2p (Figure 4d). Thus, these
results indicate that phosphorylation of Ste11p is required
to transduce the signal in several MAP kinase modules.
Importantly, in all these situations, Ste20p is thought to
function upstream of Ste11p, suggesting that Ste20p
directly activates Ste11p in multiple signaling pathways. 
The amino terminus of Ste11p binds its carboxy-terminal
domain in a phosphorylation-dependent manner
Overexpression of an amino-terminal deletion of Ste11p
constitutively activates the mating pathway, suggesting
632 Current Biology Vol 10 No 11
Figure 1
Phosphorylation of Ste11p by Ste20p
in vivo and in vitro. (a) Kinase-inactive
GST–Ste11p-K444R was expressed either in
wild-type cells (lanes 1–4) or in cells in which
STE20 was deleted (lane 5). A strain harboring
an empty plasmid served as a control (lane 1).
The cells were labeled with
32P-orthophosphate, treated (lanes 1,3–5) or
not treated (lane 2) with α-factor, and
GST–Ste11p-K444R (arrows) was purified
using GST affinity columns. Eluted proteins
were analyzed by autoradiography (upper
panel) and immunoblotted with anti-GST
antibodies (lower panel). (b) Kinase-inactive
GST–Ste11p-K444R was purified from yeast
and phosphorylated in vitro in the presence of
[γ-32P]ATP with purified wild-type Ste20p
(Step20p-wt, lane 6) or, as a control,
kinase-inactive Ste20p-K649R (lane 7), as
described previously [54]. Phosphorylated
proteins were separated by SDS–PAGE and
analyzed by autoradiography (upper panel) or
immunoblotting with GST antibodies (lower
panel). (c) GST–Ste11p-K444R
phosphorylated in vivo in response to
pheromones (left panel) or in vitro by purified
Ste20p (right panel) was hydrolyzed by 6 M
HCl and the amino acids separated by
electrophoresis in two dimensions on thin layer
plates [55]. Phosphorylated amino acids were
detected by autoradiography. The positions of
phosphoserine (S) and phosphothreonine (T),
as determined by ninhydrin staining, are
indicated. (d) Alignment of the amino-terminal
domain of Ste11p (S.c.) with MEKKs from
Schizosaccharomyces pombe (S.p.),
Candida albicans (C.a.), and Neurospora
(N.c.). Dark grey, identical residues; light grey,
conserved changes; asterisks, phosphorylated
residues in Ste11p. (e) Ste11p is
phosphorylated by Ste20p on Ser302 and/or
Ser306 and Thr307 in vitro. Wild-type or
mutant fragments of Ste11p (amino acids
175–424) encompassing the Ste20p
phosphorylation sites were expressed as GST
fusion proteins in E. coli and incubated in vitro
with purified Ste20p or, as a control,
kinase-inactive Ste20p-K649R as indicated.
Phosphorylated proteins were separated by
SDS–PAGE and detected by
autoradiography. Lane 1, GST; lanes 2 and 5,
GST–Ste11p175–424-wt; lane 3,
GST–Ste11p175–424-Ala3; lanes 4 and 6, no
substrate was added to the reaction. The lower
panel shows autophosphorylation of purified
Ste20p. (f) Phosphorylation of Ste11p in vivo
requires Ser302 and/or Ser306 and Thr307.
Wild-type cells expressing GST fusions of
Ste11p-Ala3 (lane 1) and Ste11p-K444R
(lane 2) were labeled with 32P-orthophosphate,
treated with α-factor and purified using GST
affinity columns as in (a). Eluted proteins
were analyzed by autoradiography (upper
panel) and immunoblotted with anti-GST
antibodies (lower panel).
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that the amino-terminal domain exerts an inhibitory func-
tion [28,29]. To determine whether the amino terminus
directly inhibits the catalytic domain, we first determined
whether the amino-terminal domain binds the catalytic
domain. Wild-type Ste11p1–424 readily coimmunoprecipi-
tated with its catalytic domain (Figure 5a), and the wild-
type or Ala3-amino-terminal domain was able to interact
with the catalytic domain in a two-hybrid assay
(Figure 5b). This interaction was also observed in ste5∆
cells (YFD229; data not shown), excluding the possibility
that Ste5p bridges binding of the two domains. Interest-
ingly, the amino-terminal fragment of the Ste11p-Asp3
mutant failed to interact with the catalytic domain
(Figure 5b), whereas all three amino-terminal constructs
were able to interact with Ste5p and Ste50p (Figure 6b).
Moreover, the catalytic domain of the constitutive allele
STE11-4, which harbors a threonine to isoleucine muta-
tion (T596I) in the catalytic domain [28], was defective
for binding to the wild-type regulatory domain
(Figure 5b), demonstrating that residues in both the
amino-terminal and the catalytic domains are required for
the interaction. Taken together, these results suggest that
phosphorylation of the amino-terminal domain of Ste11p
prevents binding to its catalytic domain, thereby leading
to activation of the kinase (Figure 5c). These results do
not, however, exclude the possibility that phosphoryla-
tion of the amino-terminal domain of Ste11p controls
binding to as yet unidentified regulators that may either
inhibit or activate the kinase. 
To test these models further, we examined the pheromone
response of wild-type cells expressing different fragments
of the amino-terminal inhibitory domain of Ste11p
(Figure 6). We found that overexpression of Ste11p1–424
potently prevented halo formation (Figure 6c); however, at
least when assessed by mutational analysis, inhibition was
independent of the phosphorylation state of the fragment,
suggesting that this effect was not solely due to binding its
catalytic domain. Because the Ste11p activators Ste5p and
Ste50p bound with comparable efficiency to the phospho-
rylated (Ste11p-Asp3) or non-phosphorylated (Ste11p-
Ala3) amino-terminal domain of Ste11p (Figure 6b), we
believe that Ste11p1–424 inhibits signal transduction in
response to pheromones by blocking access of wild-type
Ste11p to Ste5p and/or Ste50p. In contrast, Ste11p55–353
was unable to interact with Ste5p and Ste50p (Figure 6a),
but was able to inhibit halo formation in a phosphorylation-
dependent manner (Figure 6c), suggesting that Ste11p55–353
inhibits the catalytic domain of Ste11p in vivo. Thus, we
propose that the amino-terminal domain of Ste11p pre-
vents activation of wild-type Ste11p in response to
pheromones in at least two ways: first, it blocks binding of
Ste11p to the activators Ste5p and Ste50p, and second, it
binds and thereby inhibits its catalytic domain. 
Discussion
Despite the general importance of MAP kinase pathways, it
is not understood how these modules are activated in
response to extracellular signals. Here, we have provided
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Figure 2
Phosphorylation of Ste11p is required in vivo
during mating and is sufficient to activate the
mating MAP kinase pathway downstream of
Ste20p. YMP518 (ste11∆) cells transformed
with an empty control plasmid (vector), or a
plasmid expressing either wild-type Ste11p,
Ste11p-Ala3 or Ste11p-Asp3 from the
endogenous promoter were analyzed for their
ability to (a) mate, (b) arrest the cell cycle, and
(c) induce the transcriptional reporter
FUS1–lacZ. The activity of the signaling
pathway was quantified and expressed as
Miller units with standard deviations.
(d,e) When overexpressed from the GAL
promoter, only Ste11p-Asp3 and Ste11p-4
(T596I; [28]) but not wild-type Ste11p,
Ste11p-Ala3, or a kinase-inactive
Ste11p-Asp3-K444R induced expression of
FUS1–lacZ in wild-type cells in the absence of
α-factor. The activity of the pathway was
quantified and expressed in Miller units with
standard deviations. (f) Induction of
FUS1–lacZ by overexpression of
Ste11p-Asp3 required Ste7p (YFD53) but
was independent of Ste20p (YFD199). The
activity of the signaling pathway was quantified
and expressed as percentage Miller units
relative to wild-type controls (MPG203).    Current Biology   
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evidence that the yeast MEKK Ste11p is directly phospho-
rylated by the PAK-like kinase Ste20p in vivo. The residues
that are phosphorylated by Ste20p in vitro are important for
Ste11p function in vivo, suggesting that phosphorylation of
Ste11p by Ste20p is crucial for its activation. Using phos-
phorylation-site mutants, we have further shown that phos-
phorylation of Ste11p does not alter its interaction with
Ste5p or Ste50p, but relieves binding of the amino-terminal
inhibitory domain to its catalytic domain. Taken together,
our results suggest a molecular mechanism for the activa-
tion of Ste11p, and support the idea that Ste20p may
directly activate Ste11p in vivo. 
Ste20p may phosphorylate and thereby regulate Ste11p
in vivo
Our results suggest that Ste20p is a direct activator of
Ste11p. Ste20p functions upstream of Ste11p in the signal-
ing pathways triggered by pheromones, high osmolarity or
low nitrogen conditions [4]. Phosphorylation of Ste11p
in vivo is induced by pheromones in a STE20-dependent
manner, suggesting that Ste20p is needed to phosphorylate
634 Current Biology Vol 10 No 11
Figure 3
Overexpression of Ste11p-Ala3 interferes with
pheromone-induced cell-cycle arrest and
signal transduction in a dominant-negative
manner. Wild-type cells (YMP518)
transformed with an empty control plasmid
(vector) or a plasmid overexpressing either
wild-type Ste11p or Ste11p-Ala3 from the
GAL promoter were analyzed for their ability
to (b) arrest the cell cycle and (c) induce the
transcriptional reporter FUS1–lacZ. The
activity of the signaling pathway was
quantified as described and expressed as
Miller units. (a) Immunoblotting with specific
antibodies confirmed that the Ste11 proteins
were expressed at similar levels.
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Figure 4
Phosphorylation of Ste11p is required for the formation of pseudohyphae
and growth in high osmolarity medium. (a) YFD147 (ste11∆) cells
harboring plasmids expressing, from the endogenous promoter, wild-type
Ste11p (Step11p-wt), Ste11p-Ala3, or Ste11p-Asp3 were grown on
SLAD medium and photographed after three days. (b,c) SO419 (ste11
ssk1) cells were transformed with plasmids expressing either Ste11p-wt
(lane 2), Ste11p-Ala3 (lane 3) or Ste11p-Asp3 (lane 4) from the
inducible GAL promoter and analyzed for their ability to (b) activate the
MAP kinase Hog1p by phosphorylation of Tyr176 or (c) grow on medium
containing 1 M NaCl. As controls, SO419 cells were also transformed
with an empty plasmid (vector, lane 1) or a plasmid expressing Ssk1p
(lane 5). Extracts were prepared from cells treated (lower panel) or not
treated (upper panel) with 1 M NaCl, and tyrosine phosphorylation of
Hog1p was examined by immunoblotting with the anti-phosphospecific
p38 antibody (New England Biolabs). Arrow, position of tyrosine-
phosphorylated Hog1p. The hog1∆ strain (YFD200) controls for the
specificity of the antibody (lane 6). (d) Overexpression of Ste11p-Asp3 is
lethal because it constitutively activates both the mating and the high
osmolarity pathways. The following strains were analyzed: wild type
(K699), ste7∆ (SO417), pbs2∆ (SO416), and pbs2∆ ste7∆ (SO418).
Ste11p-Asp3 was expressed from the inducible GAL promoter; cells
were grown on media containing glucose (left plate, Ste11p-Asp3 not
expressed) or galactose (right plate, Ste11p-Asp3 expressed).  Current Biology   
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Ste11p in vivo. Nevertheless, this result does not exclude
the possibility that Ste11p may be phosphorylated by a
kinase functioning downstream of Ste11p by a feedback
mechanism, as has been observed for Ste7p [30,31]. Puri-
fied Ste20p phosphorylated Ste11p on Ser302 and/or
Ser306 and Thr307, and a Ste11p mutant protein lacking
these sites was no longer phosphorylated in vivo. Interest-
ingly, these residues are located in the regulatory domain
of Ste11p and comprise a motif that is conserved in
MEKKs from several species. Ser302 contains a K/R-
charged residue at the –3 position, consistent with the sub-
strate consensus sequence established for PAK-like
kinases using an oriented peptide library [32]. The sites
also resemble Ser308 on Raf-1, which is phosphorylated by
PAK3 [17], but varies slightly from the consensus sequence
deduced for phosphorylation of myosin I [33,34]. As more
phosphorylation sites for PAK-like kinases are discovered,
it may be possible to identify a more accurate substrate
consensus site for PAK-like kinases. 
The sites phosphorylated by Ste20p in vitro are required for
Ste11p function in vivo. Our results are mainly based on
mutational analysis and we have not rigorously shown that
these sites are indeed phosphorylated in a pheromone-
dependent manner. Several lines of evidence strongly argue
against a solely structural role of this motif. First, although
mutating these amino acids to alanine residues abolished
Ste11p function, changing these residues to aspartic acid
constitutively activated the kinase in vivo. Second, all
Ste11p mutants were able to interact with Ste5p and Ste50p,
which both bind to the regulatory domain of Ste11p. Third,
the Ste11p-Ala3 regulatory domain interfered with signaling
in vivo in a dominant-negative manner and was able to inter-
act with its catalytic domain. Finally, phosphorylation of
more than one of these residues was necessary for full activa-
tion of Ste11p; mutations that changed only Ser302 or
Ser306 into alanine residues were still able to restore the
mating defect of ste11∆ cells (data not shown). In addition,
changing Ser302 to aspartic acid led only to a very weakly
activated form of Ste11p. Taken together, these results
strongly argue that phosphorylation of these residues by
Ste20p is required to regulate the function of Ste11p in vivo.
Ste20p localizes to the plasma membrane by either binding
to the small GTPase Cdc42p [35,36] or the Gβγ het-
erodimer of the activated G protein [9]. To allow efficient
phosphorylation of Ste11p by Ste20p, it is thus likely that
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Figure 5
Phosphorylation of Ste11p relieves
intramolecular inhibition of the catalytic
domain by its regulatory domain. (a) Binding
of the amino-terminal domain of Ste11p
(Ste11p1–424) to the carboxy-terminal catalytic
domain (Ste11p424–738) was determined by
coimmunoprecipitation assay. Extracts
prepared from cells expressing Ste11p1–424
tagged with the hemagglutinin (HA) epitope
tag (HA–wt-reg), and GST–Ste11p424–738
(GST–wt-kin) were incubated with anti-HA
antibodies and the immunoprecipitates
(lanes 4–6) were examined by immunoblotting
with antibodies against GST (upper panel) or
HA (lower panel). Cells transformed with a
control vector expressing GST were analyzed
as indicated (lanes 1,4). An aliquot of the
supernatant before immunoprecipitation was
included to verify expression of the proteins
(lanes 1–3). Arrow, GST–Ste11p424–738;
arrowheads, immunoglobulin chains (lanes
4–6); asterisk, a protein that is nonspecifically
recognized by the antibodies; bracket, GST
(lanes 1–3). (b) Binding of the amino-terminal
domain of Ste11p to the carboxy-terminal
catalytic domain was examined by yeast
two-hybrid analysis. The amino-terminal
fragments of wild-type (wt) or mutant forms
(Ala3, Asp3) of Ste11p were fused to the
LexA DNA-binding domain (DBD) and
expressed with the catalytic domain of either
wild-type Ste11p or Ste11p-4 fused to the
Gal4 activation domain (AD). Two-hybrid
assays were performed as described [48]
and expressed as Miller units, with standard
deviations determined in at least three
independent experiments. (c) Model for the
activation of Ste11p in response to
extracellular stimuli. In the absence of an
activating signal, the regulatory domain of
Ste11p binds and inhibits its own catalytic
domain. The signal activates the PAK-like
kinase Ste20p, which phosphorylates Ste11p
on three sites in the amino terminus, leading
to dissociation of the inhibitory domain,
thereby allowing autophosphorylation and
activation of the Ste11p kinase. N, amino
terminus; C, carboxyl terminus. For further
details, see text. 
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Ste11p must be targeted to the plasma membrane. In the
mating pathway, Ste11p binds to Ste5p, which is recruited
to the plasma membrane in response to pheromones by
binding to Gβγ [5–8], suggesting that Ste5p may bring
Ste11p into close proximity of Ste20p, thereby allowing its
phosphorylation. In response to high osmolarity or filamen-
tous growth conditions, recruitment of Ste20p to the plasma
membrane requires Cdc42p [23,35,36], but it is not known
how Ste11p is targeted to Ste20p in these pathways [24].
Phosphorylation of Ste11p by Ste20p may release the
intramolecular inhibition of its catalytic domain
Our studies suggest a mechanism whereby Ste20p acti-
vates Ste11p in vivo. We propose that, in the absence of a
signal, the amino-terminal regulatory domain of Ste11p
inhibits the catalytic domain, thereby keeping the kinase
inactive (Figure 5c). Consistent with this model, the
amino-terminal domain of Ste11p was unable to interact
with full-length Ste11p-Ala3, suggesting that the catalytic
domain is quantitatively bound to its regulatory domain in
the absence of activating signals (data not shown). Binding
of the inhibitory domain requires residues adjacent to the
DFG motif [37], which is located in the deep cleft between
the two lobes of the kinase structure [38]. Interestingly,
several kinase inhibitors including the drug H7 have been
shown to bind to this position [39], suggesting that the
amino-terminal domain of Ste11p may reach into the cleft
and directly inhibit substrate binding or catalysis. Consis-
tent with this model, overexpression of a non-phosphorylat-
able mutant form interfered with Ste11p function in a
dominant-negative manner. In the mating pathway, this
dominant-negative effect is mediated by at least two mech-
anisms. First, the amino-terminal domain binds to Ste5p
and Ste50p in a phosphorylation-independent manner, and
may thus block access of wild-type Ste11p to its activators.
Second, the amino-terminal domain of Ste11p binds to its
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Inhibition of Ste11p signaling in vivo by an amino-terminal fragment that
is unable to interact with Ste5p and Ste50p. (a) The interaction
between full-length or amino-terminal fragments of Ste11p
(schematically represented on the left) with Ste5p (left column) or
Ste50p (right column) was determined by yeast two-hybrid analysis.
Full-length Ste5p and Ste50p were fused to the Gal4-AD; full-length or
amino-terminal fragments of Ste11p were fused to the LexA DBD. Two-
hybrid assays were performed as described [48] and shown as Miller
units with standard deviations averaged from three independent
experiments. N, amino terminus; C, carboxyl terminus; ND, not
determined. Note that Ste11p55–353 does not interact with Ste5p and
Ste50p. (b) Binding of Ste50p (left panel) or Ste5p (right panel) to
either wild-type (wt) or mutant forms (Ala3, Asp3) of the amino-terminal
domain of Ste11p (Ste11p1–424) was examined by two-hybrid analysis.
The amino-terminal fragments of wild-type or mutant forms of Ste11p
were fused to the LexA DBD and expressed with full-length Ste5p or
Ste50p fused to the Gal4 AD. Two-hybrid assays were performed as
described [47] and expressed as Miller units with standard deviations
determined in at least three independent experiments. Note that Ste5p
and Ste50p bind to the amino-terminal domain of Ste11p in a
phosphorylation-independent manner. (c) Wild-type cells (YMP288)
harboring an empty plasmid (vector; right column) or expressing, from
the inducible GAL promoter, either wild-type (left column) or the Asp3
mutant form (Asp3; middle column) of Ste11p1–424 (upper row),
Ste11p55–353 (middle row) or Ste11p174–353 (bottom row) were
analyzed by halo assay for their ability to arrest the cell cycle in
response to α-factor. Note that expression of Ste11p55–353-Ala3 but not
of Asp3 interferes with cell-cycle arrest in response to pheromones.
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catalytic domain and inhibits its function. We propose that,
in response to extracellular signals, phosphorylation of the
amino-terminal domain of Ste11p by Ste20p results in dis-
sociation of the inhibitory domain from the catalytic
domain, thereby allowing activation of Ste11p (Figure 5c).
The phosphorylated residues may directly bind to the
DFG loop, or phosphorylation may induce a structural
change that prevents interaction of the inhibitory domain
with the substrate cleft. Although we cannot exclude the
possibility that phosphorylation of Ste11p may also regulate
binding of as yet unknown regulators or influence its sub-
cellular localization or stability, the finding that mutations
in both the regulatory (STE11-ASP3) and catalytic domain
(STE11-4) of Ste11p abolished their interaction and consti-
tutively activated the kinase in vivo is consistent with our
model of intramolecular inhibition. Finally, genetic experi-
ments suggest that Ste20p cooperates with Ste50p to acti-
vate Ste11p [20] (data not shown), and Ste50p interacts
with the amino-terminal region of Ste11p [20,21,40] in a
phosphorylation-independent manner (Figure 6b). It has
been proposed that Ste50p interferes with the interaction
between the amino-terminal and the catalytic domain of
Ste11p [20], and overexpression of Ste50p was able to sup-
press the mating defect of ste20∆ cells (data not shown).
Thus, binding of the amino-terminal domain of Ste11p to
Ste50p and phosphorylation by Ste20p may together
abolish its interaction with the catalytic domain of Ste11p,
leading to full activation of the kinase.
PAK-like kinases: general activators of MEKKs? 
In a number of species, PAK-like kinases are known to
activate MAP kinase signaling pathways in a manner analo-
gous to that in yeast [1]. In Drosophila, the Ste20/PAK-like
kinase misshapen (msn) is required upstream of a MAP
kinase cascade involved in dorsal closure during late stages
of embryogenesis [41], and may function downstream of
the Frizzled receptor in planar polarity signaling [42].
Likewise, a constitutive form of human PAK1 is sufficient
to activate the JNK pathway in mammalian cells [43]. The
substrates of PAK-like kinases in these signaling pathways
are not known, but it has recently been found that PAK3
phosphorylates mammalian Raf-1 on a site which is func-
tionally important in vivo [17], suggesting that mammalian
PAK-like kinases, like their yeast counterparts, may
directly phosphorylate and activate MEKKs and members
of the Raf family of protein kinases. Phosphorylation of
human MEKK1 is observed in response to genotoxic
agents, and deletion of the amino-terminal regulatory
domain of MEKK1 kinases renders the kinase constitu-
tively active [44,45], suggesting that mammalian MEKKs
may similarly be regulated by intramolecular inhibition.
Interestingly, the amino-terminal domain of MEKK1 is
cleaved by caspase 3, which may constitutively activate the
kinase in apoptotic cells [44,45]. Thus, it is possible that
phosphorylation of the amino-terminal domain may
reversibly relieve intramolecular inhibition of MEKK1,
while the kinase may be irreversibly activated by prote-
olytic processing of the regulatory domain. Taken together,
our results provide a possible molecular mechanism for the
activation of MEKKs, and strongly support the idea that
PAK-like kinases function as direct activators of MEKKs in
multiple MAP kinase pathways.
Materials and methods
Strains, media and genetic techniques
Standard yeast growth conditions were used as described [46]. NaCl
(Sigma) was used at a final concentration of 1 M as indicated. For
α-factor treatment, cells were grown in liquid YEPD or synthetic
medium, and α-factor in 0.001 M HCl was added to a final concentra-
tion of 0.005 mg/ml. Yeast strains were derived from the W303 (ade2-1
trp1-1 leu2-3,112 ura3 his3-11,15 can1-100) or EG123 (trp1-1
leu2-3,112 ura3 his4 can1) background. Gene disruptions were con-
firmed by phenotypic analysis and/or PCRs with gene-specific primers.
Plasmid construction and site-directed mutagenesis
Standard molecular biology techniques were used [47]. Full-length or
amino-terminal fragments of STE11 were amplified by PCR using
genomic DNA as a template, digested with BamHI and XhoI and
ligated into pRD53 or pRD56, which allows expression of Ste11p or
GST–Ste11p from the inducible GAL promoter. The following primers
were used: full-length STE11, oTP438 (5′-CCTCTCGAGGAAAGGC-
CTGTTTCTTCGTGCTT-3′) and oTP439 (5′-TTCGGATCCACACA-
CATGCATAAAGAGAGACC-3′); STE11(1-424), oTP476 (5′-ATATG-
GATCCACATGCATAAAGAGAGACC-3′) and oTP477 (5−GCGTCTC-
GAGTTACGTCGGTAATGAAACAATG-3′); STE11(55-353), oTP644
(5′-ATAGGATCCACTATGTACCTGGATAGC-3′) and oTP649
(5′-CGTTCTCGAGTTACAATAGTATGTCACCG-3′); STE11(174-353),
oTP646 (5′-CATGGATCCACTATGGCCACAAACTCCAATGGAG-3′)
and oTP649. Wild-type and mutant forms of full-length STE11 were
also cloned under the control of the STE11 promoter, which was
amplified with the primers oTP662 (5′-TCTAGGTTGCGGC-
CGCAGTAGTCCACCAAAGCAGGG-3′) and oTP566 (5′-TGTG-
GATCCGAATATTTTCTACTGTTTAAAGCC-3′), introducing NotI and
BamHI restriction sites. Oligo site-directed mutagenesis was carried
out with the primers oTP446 (5′-CAGAGGCCTCCGGCCGAATT-
TATTGCTGCCAATTTGGCCGG-3′) and oTP447 (5′-CAGAGGCCT-
GACGAATTTATCGATGACAATTTGGCCGG-3′) using the ExSite kit
(Stratagene) as recommended by the manufacturer. The mutations intro-
duce EagI and ClaI restriction sites and were verified by sequencing.
DNA sequences encoding residues 175–424 of Ste11p were amplified
by PCR using the primers oTP523 (5′-CGCGGGATCCTTAGCCA-
CAAACTCC-3′) and oTP477 (5′-GCGTCTCGAGTTACGTCGGTAAT-
GAAACAATGTC-3′), digested with XhoI and BamHI and cloned into
pGEX-4T (Pharmacia).
Two-hybrid assays
Two-hybrid assays were performed in yeast strain EGY48, YMP290
(bar1-1 far1∆) or YFD229 (bar1-1 ste5∆) using pEG202-based plas-
mids expressing LexA DNA-binding domain fusions (DBD), and
pJG4-5-based plasmids containing fusions to the B42 transcriptional
activation domain (AD) [24]. Plasmids pEG203 and pJG4-6 are deriva-
tives of pEG202 and pJG4-5, respectively, with an altered polylinker
(kind gift of E. O’Shea). The regulatory domain of STE11 was amplified
by PCR with the primers oTP476 and oTP477 and cloned as a
BamHI–XhoI fragment into pEG202, whereas the catalytic domain of
STE11 or STE11-4 was amplified with the primers oTP475
(5′-ATTGTTGAATTCCCGACGAAAATTGCCACGCCC-3′) and
oTP438 and cloned as a EcoRI–XhoI fragment into pJG4-5. The full-
length STE11 coding sequence was amplified by PCR with the primers
oTP476 and oTP438 using genomic DNA as a template, digested with
BamHI and XhoI, and ligated into pEG202 and pJG4-5, respectively.
Full-length STE50 and STE5 were amplified as above using primers
oTP494 (5′-GCAGAATTCATGGAGGACGGTAAACAGGC-3′) and
oTP510 (5′-TCCCTCGAGCAAACATGAAAATAAGGCCAAGCC-3′),
or oTP564 (5′-TTTCCCATGGTGGAAACTCCTACAGACAATATA-
GTTTCC-3′) and oTP565 (5′-CTAAGAAGAACTGGGCCCACTTCA-
AATTCACGG-3′). The fragments were digested with EcoRI and XhoI,
and NcoI and ApaI, respectively, and ligated into pJG4-5 or pJG4-6.
LacZ reporter activity was measured as described previously [48];
averages and standard deviations were determined from at least three
independent experiments. When possible, two-hybrid interactions were
confirmed with both DNA- and activation domain fusions.
Sequence alignments and structural analysis
Database searches were performed using SGD (Stanford University)
and the NCBI BLAST programs (NIH). The structural coordinates were
downloaded from the protein database (http://www.rcsb.org/pdb/.)
and analyzed using Swiss-PDB Viewer [49]. 
Mating, cell-cycle arrest, FUS1–lacZ, and pseudohyphal
growth assays
Cell-cycle arrest, morphology and mating assays were carried out as
described [50]. Mating assays were performed with the tester strains
IH2625 (MATα lys1 far1-c) and IH1793 (MATα lys1). Cells deleted for
STE11 (YMP518) were transformed with plasmids expressing wild-
type or mutant Ste11p from endogenous or the GAL promoter and
assayed either on medium containing glucose (2% final concentration,
low expression levels of Ste11p) or galactose (2% final concentration,
high expression levels of Ste11p). The FUS1::lacZ::LEU2 integrating
reporter gene, from plasmid pFC23 [23], was introduced into wild-type
or strains containing mutations in STE genes as indicated; lacZ expres-
sion was measured as described previously [50]. Pseudohyphal
growth assays were carried out on SLAD medium as described [23].
Colonies were photographed after three days.
Western blots, antibodies and detection of phosphorylated
Hog1p
Protein extracts and immunoblots were carried out as described previ-
ously [51]. Phosphorylated Hog1p was assayed as described [23]
using the anti-phospho-specific p38 antibody (New England Biolabs).
Nuclear translocation of Hog1p–GFP was observed as described [52]. 
Coimmunoprecipitation experiments, purification of GST
proteins and in vitro kinase assays
Coimmunoprecipitation experiments were carried out with mono-
clonal HA antibodies (11HA; Babco) as described previously [53];
cells carrying a plasmid encoding the catalytic domain of Ste11p
fused to GST (pDP901), and either a control plasmid expressing
GST (pRD56) or plasmids expressing wild-type or mutant forms of
the HA-tagged regulatory domain (pFD196) from the inducible GAL
promoter were used. GST fusions to the amino-terminal domain of
wild-type or mutant Ste11p were expressed in E. coli (DH5α) and
purified using standard procedures [54]. Purification of wild-type and
kinase-inactive Ste20p from yeast and kinase assays were carried
out as described [35].
32P-orthophosphate labeling and purification of
phosphorylated GST–Ste11p from yeast
Cells expressing either GST, GST–Ste11p-K444R or GST–Ste11p-
Ala3 from the inducible GAL promoter were grown to mid-log phase at
30°C in synthetic medium containing 2% galactose. Cells were then
washed twice with phosphate-depleted medium [55] and grown for an
additional 2 h in phosphate-depleted medium at 30οC. Cells were con-
centrated by centrifugation, resuspended in phosphate-depleted
medium containing 32P-orthophosphate (500 µCi/ml; New England
Nuclear) and, where indicated, 10 µM α-factor, and labeled for 30 min
at 30οC. Cells were pelleted, washed with ice-cold phosphate-buffered
saline (PBS: 8.1 mM Na2HPO4, 1.5 mM KH2PO4, 137 mM NaCl,
2.7 mM KCl, pH 7.2) and lysed in ice-cold RIPA buffer (50 mM Tris
pH 8.0, 50 mM NaCl, 1% NP40, 0.5% deoxycholate, 0.1% SDS) using
glass beads. Extracts were incubated with glutathione beads for
30 min, washed extensively with ice-cold RIPA supplemented with free
phosphate, and bound proteins were eluted in PBS containing 10 mM
glutathione. Phosphorylated proteins were analyzed by SDS–PAGE
and autoradiography. Phospho-amino acid analysis of Ste11p was
carried out as described [56].
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